Full Year 2024 Guidance: 7% to 9% sales growth, 11% to 13% profit growth. GSK PLC (NYSE:GSK) reported a 9% sales growth and 19% profit growth year-to-date, reflecting strong performance in ...

Teva Pharmaceutical Industries Ltd. ADR-0.81% $21.06B ...

Looking ahead, GSK maintains its guidance for the full year of 2024, expecting turnover growth between 7% to 9% and core operating profit growth between 11% to 13%. The company is optimistic about ...

As of October 31, 2024, GSK plc (ADR) had a $73.6 billion market capitalization, putting it in the 96th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc (ADR)’s ...

GSK has revealed updated results from its phase ... 12 weeks followed by placebo – but neither performed as well as the full-dose arm. GSK is conducting trials of bepirovirsen with other ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom ...

People admire him not only for his great performance on the field but also for his interesting full name. As the No. 2 overall pick in the 2023 NFL Draft, Stroud has led the Houston Texans to an ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 44,467.39 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...